| Symbol | Sector | Firm | Action | Grade | Target | Mkt Cap ▼ | Base | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NVDA | Technology | Needham | Reiterates | Buy | $270 | $5.4T | — | — | — | — | — | — | — |
| TJX | Consumer Cyclical | Telsey Advisory Group | Reiterates | Outperform | $185 | $169.5B | — | — | — | — | — | — | — |
| LOW | Consumer Cyclical | Telsey Advisory Group | Reiterates | Outperform | $280 | $122.3B | — | — | — | — | — | — | — |
| INTU | Technology | BMO Capital Markets | Reiterates | Outperform | $412 | $113.1B | — | — | — | — | — | — | — |
| MDT | Healthcare | Goldman | Reiterates | Neutral | $84 | $101.4B | — | — | — | — | — | — | — |
| FDX | Industrials | Citigroup | Reiterates | Buy | $443 | $91.1B | — | — | — | — | — | — | — |
| OXY | Energy | Goldman | Upgrade | Sell → Neutral | $64 | $60.7B | — | — | — | — | — | — | — |
| TGT | Consumer Defensive | Telsey Advisory Group | Reiterates | Outperform | $150 | $58.0B | — | — | — | — | — | — | — |
| AEE | Utilities | JP MorganB | Upgrade | Neutral → Overweight | $126 | $29.6B | — | — | — | — | — | — | — |
| GEHC | Healthcare | UBSB | Upgrade | Sell → Neutral | $69 | $28.3B | — | — | — | — | — | — | — |
| BRO | Financial Services | Citizens | Initiates | Mkt Outperform | $70 | $18.0B | — | — | — | — | — | — | — |
| DT | Technology | William Blair | Reiterates | Outperform | — | $12.1B | — | — | — | — | — | — | — |
| SAIL | Technology | Roth Capital | Initiates | Buy | $19 | $8.1B | — | — | — | — | — | — | — |
| MBLY | Consumer Cyclical | Berenberg | Downgrade | Buy → Hold | $11 | $7.9B | — | — | — | — | — | — | — |
| ETSY | Consumer Cyclical | ArgusD | Upgrade | Hold → Buy | $67 | $7.1B | — | — | — | — | — | — | — |
| VFC | Consumer Cyclical | Citigroup | Initiates | Neutral | $18 | $6.6B | — | — | — | — | — | — | — |
| JBTM | Industrials | Oppenheimer | Initiates | Outperform | $175 | $6.5B | — | — | — | — | — | — | — |
| PTGX | Healthcare | Wolfe Research | Initiates | Outperform | $135 | $6.3B | — | — | — | — | — | — | — |
| KD | Technology | Susquehanna | Downgrade | Positive → Neutral | $13 | $2.9B | — | — | — | — | — | — | — |
| IRD | Healthcare | Leerink Partners | Initiates | Outperform | $10 | $2.7B | — | — | — | — | — | — | — |